Ribaldone DG, Caviglia GP, Gaia S, Rolle E, Risso A, Campion D, Brunocilla PR, Saracco GM, Carucci P. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy. Current Oncology 2022;29:1422-9. [DOI: 10.3390/curroncol29030119][Reference Citation Analysis]
2
Zhang Q, Pan J, An F, Nie H, Zhan Q. Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma. Bioengineered 2021;12:8147-56. [PMID: 34615436 DOI: 10.1080/21655979.2021.1987131][Reference Citation Analysis]